Onchocerciasis: the role of Wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis, and treatment F Tamarozzi, A Halliday, K Gentil, A Hoerauf, E Pearlman, MJ Taylor Clinical microbiology reviews 24 (3), 459-468, 2011 | 184 | 2011 |
Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a … R Lazarus, S Baos, H Cappel-Porter, A Carson-Stevens, M Clout, ... The Lancet 398 (10318), 2277-2287, 2021 | 155 | 2021 |
A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis A Halliday, AF Guimaraes, HE Tyrer, HM Metuge, CNW Patrick, ... Parasites & vectors 7, 1-14, 2014 | 69 | 2014 |
Innate activation of human primary epithelial cells broadens the host response to Mycobacterium tuberculosis in the airways AK Reuschl, MR Edwards, R Parker, DW Connell, L Hoang, A Halliday, ... PLoS pathogens 13 (9), e1006577, 2017 | 64 | 2017 |
The effect of placental malaria infection on cord blood and maternal immunoregulatory responses at birth KL Flanagan, A Halliday, S Burl, K Landgraf, YJ Jagne, F Noho‐Konteh, ... European journal of immunology 40 (4), 1062-1072, 2010 | 62 | 2010 |
Interleukin-4 activated macrophages mediate immunity to filarial helminth infection by sustaining CCR3-dependent eosinophilia JD Turner, N Pionnier, J Furlong-Silva, H Sjoberg, S Cross, A Halliday, ... PLoS pathogens 14 (3), e1006949, 2018 | 56 | 2018 |
The TLR2/6 ligand PAM2CSK4 is a Th2 polarizing adjuvant in Leishmania major and Brugia malayi murine vaccine models A Halliday, JD Turner, A Guimarães, PA Bates, MJ Taylor Parasites & Vectors 9, 1-9, 2016 | 51 | 2016 |
Stratification of latent Mycobacterium tuberculosis infection by cellular immune profiling A Halliday, H Whitworth, SH Kottoor, U Niazi, S Menzies, H Kunst, ... The Journal of infectious diseases 215 (9), 1480-1487, 2017 | 45 | 2017 |
Transcriptomic signatures for diagnosing tuberculosis in clinical practice: a prospective, multicentre cohort study LT Hoang, P Jain, TD Pillay, M Tolosa-Wright, U Niazi, Y Takwoingi, ... The Lancet Infectious Diseases 21 (3), 366-375, 2021 | 40 | 2021 |
Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia M Gregorova, D Morse, T Brignoli, J Steventon, F Hamilton, M Albur, ... Elife 9, e63430, 2020 | 35 | 2020 |
Young infants exhibit robust functional antibody responses and restrained IFN-γ production to SARS-CoV-2 A Goenka, A Halliday, M Gregorova, E Milodowski, A Thomas, ... Cell Reports Medicine 2 (7), 2021 | 29 | 2021 |
Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan A Halliday, PA Bates, ML Chance, MJ Taylor Parasites & vectors 9, 1-14, 2016 | 28 | 2016 |
Predisposing factors to acquisition of acute respiratory tract infections in the community: a systematic review and meta-analysis A Hammond, A Halliday, HV Thornton, AD Hay BMC infectious diseases 21, 1-11, 2021 | 25 | 2021 |
CD4+ T cell cytokine responses to the DAR-901 booster vaccine in BCG-primed adults: a randomized, placebo-controlled trial T Masonou, DA Hokey, T Lahey, A Halliday, LC Berrocal-Almanza, ... PLoS One 14 (5), e0217091, 2019 | 23 | 2019 |
Old World cutaneous leishmaniasis treatment response varies depending on parasite species, geographical location and development of secondary infection WS Al-Salem, C Solórzano, GD Weedall, NA Dyer, L Kelly-Hope, ... Parasites & vectors 12, 1-9, 2019 | 21 | 2019 |
Eosinophil-mediated immune control of adult filarial nematode infection can proceed in the absence of IL-4 receptor signaling N Pionnier, H Sjoberg, J Furlong-Silva, A Marriott, A Halliday, J Archer, ... The Journal of Immunology 205 (3), 731-740, 2020 | 19 | 2020 |
Prolonged T-cell activation and long COVID symptoms independently associate with severe COVID-19 at 3 months M Santopaolo, M Gregorova, F Hamilton, D Arnold, A Long, A Lacey, ... Elife 12, e85009, 2023 | 17 | 2023 |
Immunodiagnosis of active tuberculosis A Halliday, T Masonou, M Tolosa-Wright, V Mandagere, A Lalvani Expert review of respiratory medicine 13 (6), 521-532, 2019 | 16 | 2019 |
Predicting progression to active tuberculosis: a rate-limiting step on the path to elimination A Lalvani, LC Berrocal-Almanza, A Halliday PLoS Medicine 16 (5), e1002814, 2019 | 13 | 2019 |
Evaluation and deployment of isotype-specific salivary antibody assays for detecting previous SARS-CoV-2 infection in children and adults AC Thomas, E Oliver, HE Baum, K Gupta, KL Shelley, AE Long, HE Jones, ... Communications Medicine 3 (1), 37, 2023 | 8 | 2023 |